S&P 500   3,778.05 (-0.46%)
DOW   30,901.01 (-0.29%)
QQQ   312.40 (-0.62%)
AAPL   127.69 (-0.95%)
MSFT   213.41 (+0.18%)
FB   251.28 (+2.30%)
GOOGL   1,736.77 (+0.34%)
AMZN   3,103.50 (-0.77%)
TSLA   825.13 (-2.35%)
NVDA   517.85 (-1.92%)
BABA   242.65 (-0.14%)
CGC   33.84 (-2.25%)
GE   11.40 (-2.23%)
MU   81.17 (-0.16%)
AMD   88.96 (-2.02%)
T   29.19 (-0.34%)
NIO   56.38 (-7.38%)
F   9.93 (-2.36%)
ACB   12.04 (+0.67%)
BA   205.08 (-2.30%)
DIS   171.27 (-1.25%)
NFLX   498.35 (-0.50%)
GILD   63.21 (+1.30%)
S&P 500   3,778.05 (-0.46%)
DOW   30,901.01 (-0.29%)
QQQ   312.40 (-0.62%)
AAPL   127.69 (-0.95%)
MSFT   213.41 (+0.18%)
FB   251.28 (+2.30%)
GOOGL   1,736.77 (+0.34%)
AMZN   3,103.50 (-0.77%)
TSLA   825.13 (-2.35%)
NVDA   517.85 (-1.92%)
BABA   242.65 (-0.14%)
CGC   33.84 (-2.25%)
GE   11.40 (-2.23%)
MU   81.17 (-0.16%)
AMD   88.96 (-2.02%)
T   29.19 (-0.34%)
NIO   56.38 (-7.38%)
F   9.93 (-2.36%)
ACB   12.04 (+0.67%)
BA   205.08 (-2.30%)
DIS   171.27 (-1.25%)
NFLX   498.35 (-0.50%)
GILD   63.21 (+1.30%)
S&P 500   3,778.05 (-0.46%)
DOW   30,901.01 (-0.29%)
QQQ   312.40 (-0.62%)
AAPL   127.69 (-0.95%)
MSFT   213.41 (+0.18%)
FB   251.28 (+2.30%)
GOOGL   1,736.77 (+0.34%)
AMZN   3,103.50 (-0.77%)
TSLA   825.13 (-2.35%)
NVDA   517.85 (-1.92%)
BABA   242.65 (-0.14%)
CGC   33.84 (-2.25%)
GE   11.40 (-2.23%)
MU   81.17 (-0.16%)
AMD   88.96 (-2.02%)
T   29.19 (-0.34%)
NIO   56.38 (-7.38%)
F   9.93 (-2.36%)
ACB   12.04 (+0.67%)
BA   205.08 (-2.30%)
DIS   171.27 (-1.25%)
NFLX   498.35 (-0.50%)
GILD   63.21 (+1.30%)
S&P 500   3,778.05 (-0.46%)
DOW   30,901.01 (-0.29%)
QQQ   312.40 (-0.62%)
AAPL   127.69 (-0.95%)
MSFT   213.41 (+0.18%)
FB   251.28 (+2.30%)
GOOGL   1,736.77 (+0.34%)
AMZN   3,103.50 (-0.77%)
TSLA   825.13 (-2.35%)
NVDA   517.85 (-1.92%)
BABA   242.65 (-0.14%)
CGC   33.84 (-2.25%)
GE   11.40 (-2.23%)
MU   81.17 (-0.16%)
AMD   88.96 (-2.02%)
T   29.19 (-0.34%)
NIO   56.38 (-7.38%)
F   9.93 (-2.36%)
ACB   12.04 (+0.67%)
BA   205.08 (-2.30%)
DIS   171.27 (-1.25%)
NFLX   498.35 (-0.50%)
GILD   63.21 (+1.30%)
Log in
EBR:AGS

ageas SA/NV (AGS.BR) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume923,627 shs
Average Volume670,266 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ageas SA/NV, together with its subsidiaries, engages in insurance business in Europe and Asia. It operates through Belgium, United Kingdom, Continental Europe, Asia, and Reinsurance segments. The company primarily offers property, casualty, and life insurance products, as well as pension products; and reinsurance products. Its life insurance products include risks related to the life and death of individuals; and non-life insurance products comprise accident and health, motor, fire, and other insurance products, as well as other damages to property covering the risk of property losses or claims liabilities. The company serves private individuals, as well as small, medium-sized, and large companies through independent brokers and the bank channels. ageas SA/NV was founded in 1824 and is based in Brussels, Belgium.
ageas SA/NV (AGS.BR) logo

MarketRank

Overall MarketRank

0.44 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Insurance - Life
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone+32-2-5575711
Employees10,741

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive AGS News and Ratings via Email

Sign-up to receive the latest news and ratings for AGS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











ageas SA/NV (AGS.BR) (EBR:AGS) Frequently Asked Questions

What stocks does MarketBeat like better than ageas SA/NV (AGS.BR)?

Wall Street analysts have given ageas SA/NV (AGS.BR) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but ageas SA/NV (AGS.BR) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of ageas SA/NV (AGS.BR)'s key competitors?

What other stocks do shareholders of ageas SA/NV (AGS.BR) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ageas SA/NV (AGS.BR) investors own include Roche (RHHBY), Alibaba Group (BABA), AbbVie (ABBV), BNP Paribas SA (BNP.PA) (BNP), Euronav (EURN), International Business Machines (IBM), Nokia Oyj (NOKIA), SSR Mining (SSRM), Siltronic AG (WAF.F) (WAF) and Biogen (BIIB).

Who are ageas SA/NV (AGS.BR)'s key executives?

ageas SA/NV (AGS.BR)'s management team includes the following people:
  • Mr. Bart De Smet, Exec. Chairman (Age 63, Pay $1.54M)
  • Mr. Christophe Boizard, CFO & Exec. Director (Age 61, Pay $1.07M)
  • Mr. Antonio Cano Y Bosque, MD of Europe & Exec. Director (Age 57, Pay $1.05M)
  • Mr. Emmanuel Van Grimbergen, Chief Risk Officer & Exec. Director (Age 52, Pay $629.09k)
  • Mr. Filip Andre Lodewijk Coremans, MD of Asia & Exec. Director (Age 56, Pay $1.05M)
  • Mr. Hans J. J. De Cuyper, CEO & Director (Age 51)
  • Jerry Bata, Head of Legal
  • Ms. Heidi Delobelle, Chief Exec. Officer of Belgium
  • Mr. Steven Georges Leon Braekeveldt, Chief Exec. Officer of Continental Europe (Age 60)
  • Mr. Gary Lee Crist, Chief Exec. Officer of Asia (Age 63)

What is ageas SA/NV (AGS.BR)'s stock symbol?

ageas SA/NV (AGS.BR) trades on the EBR under the ticker symbol "AGS."

What is ageas SA/NV (AGS.BR)'s official website?

The official website for ageas SA/NV (AGS.BR) is www.ageas.com.

How can I contact ageas SA/NV (AGS.BR)?

ageas SA/NV (AGS.BR)'s mailing address is Rue du Marquis 1 Bte 7, BRUXELLES, 1000, Belgium. The company can be reached via phone at +32-2-5575711.

This page was last updated on 1/15/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.